What is NovoCure's AOCI?

NovoCure (NVCR) reported AOCI of -$4.9M in Q1 2026.

How has NovoCure's AOCI changed year-over-year?

NovoCure's AOCI decreased by 16.5% year-over-year, from -$4.2M to -$4.9M.

What is the long-term trend for NovoCure's AOCI?

Over 5 years (2020 to 2025), NovoCure's AOCI has grown at a -2.1% compound annual growth rate (CAGR), from -$3.83M to -$3.44M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

NovoCure NVCR AOCI

AOCI at other companies

Boston ScientificBSX

-$398M-1,321%

MedtronicMDT

-$4.1B+4.3%

Iovance Biotherapeutics, Inc.IOVA

$12.65M+101%

Nuvation BioNUVB

-$1.68M-408%

Syndax PharmaceuticalsSNDX

$11K-97.9%

ArriVent BioPharma, Inc.AVBP

-$270K-1,488%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Enterprise value$1.66B-36.3%

P/S2.5×-1.8×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's AOCI?: NovoCure (NVCR) reported AOCI of -$4.9M in Q1 2026.
How has NovoCure's AOCI changed year-over-year?: NovoCure's AOCI decreased by 16.5% year-over-year, from -$4.2M to -$4.9M.
What is the long-term trend for NovoCure's AOCI?: Over 5 years (2020 to 2025), NovoCure's AOCI has grown at a -2.1% compound annual growth rate (CAGR), from -$3.83M to -$3.44M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.